Berlin Heart Announces Restructuring of Management

CEO Dr. Rolf Kaese leaves Berlin Heart

Berlin, (PresseBox) - The Chairman of the Advisory Board, Ulrich Stroeher has announced that the CEO and management spokesman is leaving the company to pursue other professional interests. Dr. Kaese is leaving the company at his own request, having experienced differences in long-term strategical issues with the company s associate Syscore GmbH.

After leading Berlin Heart since the acquisition through Syscore in 2006, Dr. Kaese has contributed valuably to the re-organisation of the company. "We thank Dr. Kaese for his commitment to the company s success and wish him all the best for the future", says Ulrich Stroeher, Chairman of the Advisory Board. Until the replacement of the CEO has been effected, Dr. Dipl.-Ing. Johannes Mueller, a board member will provisionally serve as the company s General Manager, while the members of the Advisory Board, Ulrich Stroeher and Dr. Mathias Herter will provide their support.

Berlin Heart GmbH

Berlin Heart GmbH is the only company worldwide offering ventricular assist devices for patients of every age and body size. The company manufactures pumps, cannulas, and external components for internal and external use to stabilize cardiac activity in acutely ill patients. Its products INCOR®, EXCOR® and EXCOR® Pediatric are market leaders in their respective segments in Germany and in Europe. The company makes technologically advanced products and therefore constitutes an important part of the medical technology growth sector in Berlin. Further product information is available from the company website: www.berlinheart.com.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.